机构：[1]Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada[2]Toronto Platelet Immunobiology Group, Toronto, ON, Canada[3]Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, ON, Canada[4]The Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, P.R. China广东省中医院深圳市中医院深圳医学信息中心[5]Canadian Blood Services, Toronto, ON, Canada[6]Department of Medicine and Department of Physiology, University of Toronto, Toronto, ON, Canada
Platelets are small versatile blood cells generated from megakaryocytes in the bone marrow and cleared in the reticuloendothelial system. Platelet accumulation (adhesion and aggregation) at the site of injury has been considered the first wave of hemostasis. Interestingly, although fibrinogen and von Willebrand factor (VWF) are documented to be essential for hemostasis, fibrinogen/VWF-independent platelet aggregation and thrombosis still occur. Following platelet activation and phosphatidylserine expression, platelets also contribute to cell-based thrombin generation and blood coagulation - the second wave of hemostasis. Most recently, deposition of fibronectin and other plasma proteins onto the injured vessel wall was identified as a "protein wave" of hemostasis, in which platelets may release their granule proteins and thus also contribute to this very early hemostatic event. Due to the central roles of platelets in hemostasis, excessive platelet clearance may lead to bleeding disorders as observed in auto-and alloimmune-mediated thrombocytopenias. In this review, we will introduce several new pathways of thrombosis and hemostasis as well as antibody Fc-independent platelet clearance, which may play an important role in immune-mediated thrombocytopenias. We will also discuss the roles of platelets in fetal hemostasis that may deserve further investigation. (C) 2016 Elsevier Ltd. All rights reserved.
第一作者机构：[1]Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada[2]Toronto Platelet Immunobiology Group, Toronto, ON, Canada[3]Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, ON, Canada[4]The Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, P.R. China
通讯作者：
通讯机构：[1]Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada[2]Toronto Platelet Immunobiology Group, Toronto, ON, Canada[3]Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, St. Michael’s Hospital, Toronto, ON, Canada[5]Canadian Blood Services, Toronto, ON, Canada[6]Department of Medicine and Department of Physiology, University of Toronto, Toronto, ON, Canada[*1]Department of Laboratory Medicine and Pathobiology, Department of Medicine and Department of Physiology, University of Toronto, Scientist of Canadian Blood Services, Platform Director for Hematology, Cancer and Immunological Diseases, St. Michael’s Hospital, Room 420, LKSKI - Keenan Research Centre, 209 Victoria Street, Toronto, Ontario, CANADA M5B 1W8.
